ADMELOG is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Insulin Lispro.
Product ID | 70518-2399_967b9b62-abe6-f0ab-e053-2995a90a7fd7 |
NDC | 70518-2399 |
Product Type | Human Prescription Drug |
Proprietary Name | ADMELOG |
Generic Name | Insulin Lispro |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
Marketing Start Date | 2019-10-30 |
Marketing Category | NDA / NDA |
Application Number | NDA209196 |
Labeler Name | REMEDYREPACK INC. |
Substance Name | INSULIN LISPRO |
Active Ingredient Strength | 100 U/mL |
Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-10-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA209196 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-10-30 |
Ingredient | Strength |
---|---|
INSULIN LISPRO | 100 U/mL |
NDC | Brand Name | Generic Name |
---|---|---|
0024-5924 | ADMELOG | ADMELOG |
0024-5926 | ADMELOG | ADMELOG |
0024-5925 | ADMELOG | ADMELOG |
70518-2399 | ADMELOG | ADMELOG |
0002-7510 | Humalog | Insulin lispro |
0002-7511 | Humalog | Insulin lispro |
0002-7512 | Humalog | Insulin lispro |
0002-7516 | Humalog | Insulin lispro |
0002-7712 | Humalog | Insulin lispro |
0002-7714 | Humalog | Insulin lispro |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() ADMELOG 87682668 5475626 Live/Registered |
Sanofi 2017-11-13 |
![]() ADMELOG 86787842 5080517 Live/Registered |
Sanofi 2015-10-14 |